EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Additional sectioning and AI ‐assisted diagnosis reveal underdiagnosis of serous (pre)malignancies in fallopian tube specimen from BRCA 1/2 carriers

Anouk B Bouwmeester iD, Tamar A Gootzen iD, Marielle Nobbenhuis iD, Vilius Rudaitis iD, Caroline B van den Berg iD, Heleen J van Beekhuizen iD, Luthy Sm Alcalá iD, Dineke Pm Smedts iD, Nicole Cm Visser iD, Viola Verhoef iD, Trudy Gn Jonges iD, Ronald P Zweemer iD und 6 weitere

Histopathology · 2026-12 · 89 (6) · 964-974

DOI: 10.1111/his.70249 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Histopathology, online erschienen am 12.08.2026. Verfasst von Anouk B Bouwmeester und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Radboudumc, Nijmegen, the Netherlands. Hauptthemen laut MEDLINE: Fallopian Tube Neoplasms, Cystadenocarcinoma, Serous, Carcinoma in Situ, Precancerous Conditions. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: KWF Kankerbestrijding.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

Germline BRCA1/2 pathogenic variant carriers are at increased risk for high‐grade serous carcinoma (HGSC) and are therefore advised to have a risk‐reducing salpingo‐oophorectomy (RRSO) around the age of 40. A risk of 0.9% to develop peritoneal HGSC (pHGSC) remains, which increases up to 27.5% when serous tubal intraepithelial carcinoma (STIC) is detected at RRSO. The relationship between the detection of STIC and the occurrence of pHGSC is still poorly understood. Here, we investigated the role of tissue sampling by examining deeper sections of the tubal tissue of RRSO specimens.

Methods

Four groups of patients were included: (1) STIC without pHGSC ( n = 5); (2) STIC with pHGSC ( n = 4); (3) no STIC and no pHGSC ( n = 5); and (4) no STIC and pHGSC ( n = 5). Follow‐up time was 10 years or until the development of pHGSC. Deeper sections were cut at 150 μm intervals. A deep learning model was used to support STIC detection.

Results

A focus of isolated STIC or HGSC was found in the deeper sections of all patients who developed pHGSC, while these patients did not have STIC or HGSC at the initial diagnosis. No patients with STIC and pHGSC showed HGSC in the deeper sections. We observed that five STICs presented as serous tubal intraepithelial lesions (STILs) in adjacent slides based on low Ki‐67 expression.

Conclusions

Our findings underscore the hypothesis that pHGSC originates in the fallopian tube and confirm that invasiveness is not necessary for disease progression of STIC towards pHGSC. Furthermore, deeper sections might be of additional value when STIL is diagnosed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fallopian Tube NeoplasmsCystadenocarcinoma, SerousCarcinoma in SituPrecancerous ConditionsOvarian NeoplasmsHumansFemaleBRCA2 ProteinBRCA1 ProteinAdultMiddle AgedFallopian TubesSalpingo-oophorectomy

Stichwörter der Autor:innen

high‐grade serous carcinomaovarian cancersalpingo‐oophorectomysampling errorserous tubal intraepithelial carcinoma

Substanzen

BRCA2 ProteinBRCA2 protein, humanBRCA1 ProteinBRCA1 protein, human

Autor:innen und Institutionen

  • Department of Pathology, Radboudumc, Nijmegen, the Netherlands.
  • Department of Gynecology and Obstetrics, Radboudumc, Nijmegen, the Netherlands.
  • Department of Gynecological Oncology, The Royal Marsden NHS Foundation Trust, London, UK.
  • Faculty of Medicine, Clinic of Obstetrics and Gynecology, Vilnius University, Vilnius, Lithuania.
  • Department of Gynecology and Obstetrics, ErasmusMC, Rotterdam, the Netherlands.
  • Department of Pathology, Amphia hospital, Breda, the Netherlands.

ORCID-Profile: Anouk B Bouwmeester, Tamar A Gootzen, Marielle Nobbenhuis, Vilius Rudaitis, Caroline B van den Berg, Heleen J van Beekhuizen, Luthy Sm Alcalá, Dineke Pm Smedts, Nicole Cm Visser, Viola Verhoef, Trudy Gn Jonges, Ronald P Zweemer, Alicia Leon-Catillo, Carlijn Lems, Joanne A de Hullu, Jeroen Awm van der Laak, Miranda P Steenbeek, Michiel Simons

Förderung

  • KWF Kankerbestrijding

Zitieren

APA

Bouwmeester, A. B., Gootzen, T. A., Nobbenhuis, M., Rudaitis, V., van den Berg, C. B., van Beekhuizen, H. J., Alcalá, L. S., Smedts, D. P., Visser, N. C., Verhoef, V., Jonges, T. G., Zweemer, R. P., Leon-Catillo, A., Lems, C., de Hullu, J. A., van der Laak, J. A., Steenbeek, M. P., & Simons, M. (2026). Additional sectioning and AI ‐assisted diagnosis reveal underdiagnosis of serous (pre)malignancies in fallopian tube specimen from BRCA 1/2 carriers. Histopathology, 89(6), 964-974. https://doi.org/10.1111/his.70249

Vancouver

Bouwmeester AB, Gootzen TA, Nobbenhuis M, Rudaitis V, van den Berg CB, van Beekhuizen HJ, et al. Additional sectioning and AI ‐assisted diagnosis reveal underdiagnosis of serous (pre)malignancies in fallopian tube specimen from BRCA 1/2 carriers. Histopathology. 2026;89(6):964-974. doi:10.1111/his.70249

BibTeX
@article{Bouwmeester2026,
  author = {Bouwmeester, Anouk B and Gootzen, Tamar A and Nobbenhuis, Marielle and Rudaitis, Vilius and van den Berg, Caroline B and van Beekhuizen, Heleen J and Alcalá, Luthy Sm and Smedts, Dineke Pm and Visser, Nicole Cm and Verhoef, Viola and Jonges, Trudy Gn and Zweemer, Ronald P and Leon-Catillo, Alicia and Lems, Carlijn and de Hullu, Joanne A and van der Laak, Jeroen Awm and Steenbeek, Miranda P and Simons, Michiel},
  title = {Additional sectioning and AI ‐assisted diagnosis reveal underdiagnosis of serous (pre)malignancies in fallopian tube specimen from BRCA 1/2 carriers},
  journal = {Histopathology},
  year = {2026},
  volume = {89},
  number = {6},
  pages = {964--974},
  doi = {10.1111/his.70249}
}
Kostenlos starten →